These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 202576)

  • 1. A new lymphoid cell line, Reh 6, with characteristics of non-T and non-B cells, lacking the Epstein-Barr virus genome and derived from human acute lymphoblastic leukemia.
    Kayibanda B; Rosenfeld C; Goutner A; Bornkamm GW
    Intervirology; 1978; 9(5):316-20. PubMed ID: 202576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an Epstein-Barr virus-determined nuclear antigen-negative human B-cell line from acute lymphoblastic leukemia.
    Hiraki S; Miyoshi I; Masuji H; Kubonishi I; Matsuda Y
    J Natl Cancer Inst; 1977 Jul; 59(1):93-4. PubMed ID: 195075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained.
    Reisman D; Sugden B
    Virology; 1984 Aug; 137(1):113-26. PubMed ID: 6089410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
    Allday MJ; MacGillivray AJ
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
    Takada K; Yamamoto K; Osato T
    Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia.
    Asada H; Okada N; Hashimoto K; Yamanishi K; Sairenji T; Hirota S; Nomura S; Kitamura Y; Yoshikawa K
    Leukemia; 1994 Aug; 8(8):1415-23. PubMed ID: 8057683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
    zur Hausen H; Fresen KO
    IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of leukaemic B lymphocytes by Epstein Barr virus.
    Doyle MG; Catovsky D; Crawford DH
    Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a new Epstein-Barr virus nuclear antigen-positive B-cell line, BALL-2, with t(8;14) (q24;q32) chromosome abnormality from B-cell acute lymphoblastic leukemia, L2.
    Kubonishi I; Daibata M; Yano S; Isobe M; Kurosawa N; Nagumo H; Ogita Z; Ohyashiki JH; Toyama K; Miyoshi I
    Am J Hematol; 1991 Jul; 37(3):179-85. PubMed ID: 1650133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
    Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
    J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.
    Klein G; Lindahl T; Jondal M; Leibold W; Menézes J; Nilsson K; Sundström C
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3283-6. PubMed ID: 4369887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.
    Gergely L; Luka J; Klein G
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():2043-8. PubMed ID: 6094716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    Allday MJ; Crawford DH; Griffin BE
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.
    Schneider U; Schwenk HU; Bornkamm G
    Int J Cancer; 1977 May; 19(5):621-6. PubMed ID: 68013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant expression of 2 Epstein-Barr virus-associated antigens, EBNA and RANA, in man-rodent somatic cell hybrids.
    Slovin SF; Glassy MC; Dambaugh T; Catalano MA; Curry RA; Ferrone S; Kieff E; Vaughan JH; Carson DA
    J Immunol; 1981 Aug; 127(2):585-90. PubMed ID: 6265553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.